openPR Logo
Press release

Clinical digital applications to safeguard the Lung Assessment Device Market

Clinical digital applications to safeguard the Lung Assessment

The healthcare vertical is growing at a rapid pace all over. There are hordes of healthcare opportunities available. Digitization is making a constructive entry to the vertical. As such, several life sciences companies are into collaborative innovation and advancements in drug- and diagnostics-related research. As such, the Lung Assessment Device Market is bound to climb the digitized pedestal in the years to come.

Lung function tests are noninvasive tests that are used to check how well the lungs are working. Lung function tests measure lung capacity, volume, rates of flow, and gas exchange. This information is helpful for diagnose and for treatment of various lung diseases such as chronic obstructive pulmonary disease (COPD), Asbestosis, asthma, emphysema, Respiratory infections, Sarcoidosis and Scleroderma.

Lungs assessment devices are used to measure Tidal volume, Residual volume, Minute volume, forced expiratory volume, total lung capacity, Vital capacity, forced vital capacity, functional residual capacity, forced expiratory flow and peak expiratory flow rate.

Get Sample Copy of the Report@ https://www.persistencemarketresearch.com/samples/32222

PulmoScan, the world's first home-usable lung assessment device investigated by Cognita Labs, issued clearance by the U.S. Food and Drug Administration (FDA) to measures airway resistance and elastance. MightSat Rx-finger pulse oximeter developed by Masimo received the USFDA approval in January 2019, to be used at home.

The COVID-19 pandemic has an impact on several industries. Due to COVID-19 outbreak, the rate of patients visiting the hospitals has declined which contributed to the reduction in the diagnosis rate of lung disease. Besides, the manufacturing industries are disturbed due to lockdown causing unparalleled technology and transfigure of business model. These might cause a disturbance in the supply of medical devices.

Rising prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary diseases (COPDs), growing geriatric population, increasing prevalence of smoking, increase in pollution levels and lifestyle changes are some of the major factors driving lung assessment device market growth.

Manufacturers in the lung assessment device market are introducing wearable strain sensors for effective management of chronic lung diseases and measurements on volume and respiration rate (RR) with high accuracy which results in lung assessment device market growth.

Increasing in healthcare expenditure, favourable medical schemes & reimbursement policies are some of the key factors that supplement the growth of lung assessment device market. Strict regulatory compliance procedures and the cost of the device may restrain the growth of the lung assessment device market.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32222

Lung assessment device market has been segmented based on Product, end-users and regions.

Product Type

Spirometer
Pulse Oximeter
Body Plethysmograph
Pulmonary Function System
Capnography
Peak Flow Meters
Gas Analyzers
Others

End Users
Home Care
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Region
North America
Latin America
Europe
South Asia
East Asia
Oceania

Middle East & Africa

Based on product, Spirometer segment dominates the lung assessment market followed by a pulse oximeter. Rising prevalence of chronic lung disorder, an increase in demand for lungs function test leads this segment to hold a major share in lung assessment device market.

Based on end-users, the hospital's segment holds for a larger share of the lung assessment device market. The home care segment is expected to have significant growth, due to an increase in the number of key participants receiving U.S.FDA approval for home use lung assessment devices.

North America is expected to hold a major share in the Lung assessment device Market due to the increasing prevalence of respiratory diseases in this region. Europe showed significant growth owing to an increase in cases of chronic lung disorders and an increase in awareness about the lung assessment tests as well as advanced healthcare structure.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32222

The Asia Pacific is also expected to have a rapid growth in the Lung assessment device Market due to the increased in government initiatives, investment of prominent company as well as advancement in the healthcare system to develop lung assessment device more user friendly.

The key participants operating in the global Lung assessment device Market are Medtronic, Novelda AS, MGC Diagnostics Corporation, Nihon Kohden Corporation, Ganshorn, Welch Allyn, Inc., Anhui Electric Science, Philips Healthcare, Drägerwerk AG & Co., Smiths Medical, Vyaire Medical Inc., KGaA, COSMED, Masimo. Becton, Dickinson and Company, MGC Diagnostics, Eco Physics and Schiller AG.

Access Related Reports-

Human Insulin Market: https://www.persistencemarketresearch.com/market-research/human-insulin-market.asp

Immunooncology Market: https://www.persistencemarketresearch.com/market-research/immunooncology-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical digital applications to safeguard the Lung Assessment Device Market here

News-ID: 2619052 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Lung

Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Lung Cancer Drugs Industry Market Size Be by 2025? The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Lending And Payments Market? The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787 This latest report researches the industry structure,
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor